Výsledky vyhledávání - "Jochen Spranger"

Leptin and Endocrine Parameters in Marathon Runners

Autor: H. M. Schulte, Lars Brechtel, Thomas Bobbert, Andreas Pfeiffer, Knut Mai, S. Diederich, Jochen Spranger, B. Weger

Publikováno v: International Journal of Sports Medicine. 33:244-248

Endurance training may lead to different hormonal alterations e. g., exercised induced hypothalamic ovarian/testicular dysfunction. The aim of this study was to reveal new connections between physical exercise, leptin and hormonal responses. 36 male

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed70a38ed49fa22e82377a8e186c17ad
https://doi.org/10.1055/s-0031-1291251

Zobrazit plný text záznamu

Effects of hyperlipidaemia on glucocorticoid metabolism: results of a randomized controlled trial in healthy young women

Autor: Andreas Pfeiffer, Stefan A. Wudy, Christiane Maser-Gluth, Thomas Bobbert, J. Kraatz, J. Andres, F. Reinecke, Knut Mai, Jochen Spranger, Michaela F. Hartmann

Publikováno v: Clinical Endocrinology. 74:551-557

Summary Objective It is well established that the hypothalamic–pituitary–adrenal (HPA) axis is altered in obese individuals. Hyperlipidaemia with elevated levels of free fatty acids (FFAs) is also frequently seen in obesity and in the metabolic s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b7d6b4b5d22549b1d44d0f5dbf394de
https://doi.org/10.1111/j.1365-2265.2011.03972.x

Zobrazit plný text záznamu

Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study

Autor: Ayman M. Arafat, Martin O. Weickert, Matthias Möhlig, Jochen Spranger, Christof Schöfl, Andreas Pfeiffer

Publikováno v: Diabetologia. 53:1304-1313

Growth hormone-deficient patients show deterioration of insulin sensitivity and beta cell function. High-dose growth hormone treatment often induces further impairment of insulin sensitivity, leading to an increase in insulin and glucose levels or ev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b894ff165a4ff52960afc95050c0a002
https://doi.org/10.1007/s00125-010-1738-4

Zobrazit plný text záznamu

A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects

Autor: Martin A. Osterhoff, Christian von Loeffelholz, Visvanathan Chandramouli, Andreas Pfeiffer, Michael Roden, Jochen Spranger, Bernard R. Landau, Peter Nowotny, Frank Isken, Martin O. Weickert, Matthias Möhlig, Attila Brehm

Publikováno v: American Journal of Physiology-Endocrinology and Metabolism. 293:E1078-E1084

Liver fatty acid-binding protein (L-FABP) is a highly conserved key factor in lipid metabolism. Amino acid replacements in L-FABP might alter its function and thereby affect glucose metabolism in lipid-exposed subjects, as indicated by studies in L-F

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da4b4e236a8f6fc19e4fefad01fb9cb2
https://doi.org/10.1152/ajpendo.00337.2007

Zobrazit plný text záznamu

Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients

Autor: Andreas Pfeiffer, Jens Raila, Andrea Henze, Florian J. Schweigert, Jochen Spranger, Matthias Möhlig

Publikováno v: Kidney International. 72:505-511

Plasma retinol-binding protein 4 (RBP4) may be a new adipokine linked to obesity-induced insulin resistance and type 2 diabetes. The impact of diabetic nephropathy on plasma RBP4 levels, however, is not known. We tested the hypothesis that microalbum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed4a45079297bfdd49fdb22cebb2735
https://doi.org/10.1038/sj.ki.5002372

Zobrazit plný text záznamu

Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia

Autor: Andreas Pfeiffer, K. G. Parhofer, R. J. A. Frost, Jochen Spranger, Bärbel Otto, Carsten Otto, M. Vogeser

Publikováno v: Acta Diabetologica. 44:65-68

Lipid-lowering therapy is associated with reduced cardiovascular risk. The aim of the present study was to investigate whether lipid-lowering therapy might be associated with changes in the concentrations of metabolically important hormone concentrat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c1388ea42b9fee36dfefde30d59e98
https://doi.org/10.1007/s00592-007-0244-8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání